Logo for Humanigen Inc

Humanigen Investor Relations Material

Latest events

Logo for Humanigen

Q4 2022

30 Mar, 2023
Logo for Humanigen

Q4 2021

1 Mar, 2022
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies

Latest reports from Humanigen Inc

Access all reports
Humanigen Inc is a biopharmaceutical company developing therapies aimed at preventing and treating immune hyper-response conditions. The company’s research focuses on addressing inflammatory and infectious diseases. Humanigen operates within the healthcare and biotechnology sectors. The company is headquartered in Short Hills, New Jersey, and its shares are listed on the NASDAQ.